Huntington’s Disease (HD) is a neurodegenerative disorder caused by the expansion of CAG repeats on the exon 1 of the HTT gene. Atrophy of the striatum is currently the main biomarker of the disease’s progression, but there is a need to find earlier and more functional biomarkers. Here, we evaluated Diffusion Tensor Imaging (DTI) and resting-state fMRI (rs-fMRI) as biomarkers in heterozygous zQ175 mice, a model mimicking the presymptomatic phase of HD. Our protocol allowed detection of vulnerable brain networks that would be of great interest for better understanding of the pathogenesis in clinical HD.
This abstract and the presentation materials are available to members only; a login is required.